Vaccination

Influenza vaccine efficacy during the 2022-2023 influenza season was “moderate” but still prevented many health care encounters and hospitalizations among adult patients, researchers determined.

Researchers determined that first-year college students living on campus and/or affiliated with campus Greek life have an increased risk for meningococcal disease.

Children who received two or more doses of COVID-19 messenger RNA vaccine were 40% less likely to be hospitalized or visit an ED due to the disease, according to findings published in MMWR.

Influenza vaccination was linked to significant decreased risks for major cardiovascular events and death, according to a study published in Scientific Reports.

A Boston-area biopharmaceutical has announced additional positive biomarker data from a phase 1/2a study of a novel cancer vaccine immunotherapeutic intended to treat those with recurrent glioblastoma.

NEW YORK — The CDC this week announced the release of more than 77,000 additional doses of nirsevimab to address an ongoing shortage of the monoclonal antibody in the United States.

To reflect advances in COPD diagnosis and treatment, the 2024 Global Initiative for Chronic Obstructive Lung Disease report features both new and revised sections.

Anti-PD-1 therapy reduces de novo production of spike-specific antibodies following vaccination from SARS-CoV-2, according to study findings presented at Society for Immunotherapy of Cancer Annual Meeting.

The FDA approved the world’s first vaccine against chikungunya virus.

Routine vaccination rates among kindergartners in the United States remained lower than pre-pandemic levels last school year as vaccine exemptions increased to an all-time high, according to data published Thursday by the CDC.